HIVE jumps 11% as $100M exchangeable-notes financing and crypto-miner strength lift shares

HIVE Digital Technologies (HIVE) is up 11.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to HIVE’s newly priced upsized US$100 million 0% exchangeable senior notes offering, which can be viewed as fresh funding for its AI/HPC buildout. The stock also traded in sympathy with strength across bitcoin-linked miners amid a firmer crypto tape, which can amplify day-to-day volatility in the group.

Details:

HIVE announced the pricing of an upsized private offering of US$100 million of 0% exchangeable senior notes due 2031 through a wholly owned subsidiary.

The initial exchange price was approximately US$2.57 per share, representing a premium to the April 16, 2026 Nasdaq close, which investors may interpret as favorable financing terms.

HIVE stated that net proceeds are intended for strategic growth initiatives including GPU purchases and data center expansion, plus general corporate purposes.

This could also reflect sector momentum: bitcoin miner/AI infrastructure names moved higher alongside a rebound in bitcoin, which often drives outsized beta in miners like HIVE.

Sources:

Newsfile, The Block, StockTitan

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive HIVE Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$HIVE Hedge Fund Activity

We have seen 80 institutional investors add shares of $HIVE stock to their portfolio, and 53 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

RENAISSANCE TECHNOLOGIES LLC added 4,230,200 shares (+inf%) to their portfolio in Q4 2025, for an estimated $10,913,916
MILLENNIUM MANAGEMENT LLC added 3,253,735 shares (+89.2%) to their portfolio in Q4 2025, for an estimated $8,394,636
GROUP ONE TRADING LLC removed 2,059,543 shares (-84.8%) from their portfolio in Q4 2025, for an estimated $5,313,620
QUBE RESEARCH & TECHNOLOGIES LTD added 1,804,168 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,654,753
JUMP FINANCIAL, LLC added 1,296,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,343,680
JANE STREET GROUP, LLC added 1,265,115 shares (+39.0%) to their portfolio in Q4 2025, for an estimated $3,263,996
CITADEL ADVISORS LLC added 1,246,363 shares (+34.6%) to their portfolio in Q4 2025, for an estimated $3,215,616

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$HIVE Analyst Ratings

Wall Street analysts have issued reports on $HIVE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Canaccord Genuity issued a "Buy" rating on 11/21/2025
B. Riley Securities issued a "Buy" rating on 11/21/2025
HC Wainwright & Co. issued a "Buy" rating on 11/18/2025
Rosenblatt issued a "Buy" rating on 11/18/2025

To track analyst ratings and price targets for $HIVE, check out Quiver Quantitative's $HIVE forecast page.

$HIVE Price Targets

Multiple analysts have issued price targets for $HIVE recently. We have seen 7 analysts offer price targets for $HIVE in the last 6 months, with a median target of $6.0.

Here are some recent targets:

Brett Knoblauch from Cantor Fitzgerald set a target price of $3.0 on 04/09/2026
Chris Brendler from Rosenblatt set a target price of $4.5 on 02/18/2026
Fedor Shabalin from B. Riley Securities set a target price of $6.0 on 02/13/2026
Stephen Glagola from Keefe, Bruyette & Woods set a target price of $3.5 on 01/27/2026
Joseph Vafi from Canaccord Genuity set a target price of $10.0 on 11/21/2025
Mike Colonnese from HC Wainwright & Co. set a target price of $10.0 on 11/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.